日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial

CheckMate 9ER 随机 III 期试验中，对纳武利尤单抗联合卡博替尼治疗晚期肾细胞癌的最终分析

期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2025.09.006
Motzer, R J; Escudier, B; Burotto, M; Powles, T; Apolo, A B; Bourlon, M T; Shah, A Y; Porta, C; Suárez, C; Barrios, C H; Richardet, M; Gurney, H; Kessler, E R; Tomita, Y; Bedke, J; Scheffold, C; Askelson, M; Panzica, J; Zhang, J; van Kooten Losio, M; Choueiri, T K
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2026
文献求助 收藏

Navigating SNAP waiver submissions: an Iowa case study

如何顺利提交 SNAP 豁免申请：爱荷华州案例研究

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2026.1771849
Buckingham-Schutt, Lyndi; Bucklin, Rebecca; Janssen, Brandi; Johnson, Joelle; Askelson, Natoshia
发表日期：2026
文献求助 收藏

A mixed-methods approach for understanding cancer center catchment area needs: An example of rural cancer disparities, needs, and resiliencies

采用混合方法了解癌症中心服务区域的需求：以农村癌症差异、需求和应对能力为例

期刊:Cancer Causes & Control
影响因子:
doi:10.1007/s10552-026-02166-9
Evett, Stephanie; Kahl, Amanda; Schmidt, Megan E; Wells Sittig, Kelly; Meyer, Meredith; Charlton, Mary; Askelson, Natoshia M; Nash, Sarah H
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204

CheckMate 204 研究中接受纳武利尤单抗联合伊匹木单抗治疗的黑色素瘤脑转移患者的颅内反应评估标准比较分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00953
Huang, Raymond Y; Youssef, Gilbert; Nelson, Thomas; Wen, Patrick Y; Forsyth, Peter; Hodi, F Stephen; Margolin, Kim; Algazi, Alain P; Hamid, Omid; Lao, Christopher D; Ernstoff, Marc S; Moschos, Stergios J; Atkins, Michael B; Postow, Michael A; Reardon, David A; Grootendorst, Diederik J; Leung, David; Askelson, Margarita; Ritchings, Corey; Tawbi, Hussein A
黑色素瘤
神经科学
发表日期：2025
文献求助 收藏

Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274

辅助性纳武利尤单抗治疗高危肌层浸润性尿路上皮癌：CheckMate 274 研究显示其疗效进一步增强

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00340
Galsky, Matthew D; Witjes, Johannes Alfred; Gschwend, Jürgen E; Milowsky, Matthew I; Schenker, Michael; Valderrama, Begoña P; Tomita, Yoshihiko; Bamias, Aristotelis; Lebret, Thierry; Shariat, Shahrokh F; Park, Se Hoon; Agerbaek, Mads; Jha, Gautam; Stenner, Frank; Ye, Dingwei; Giudici, Fabio; Dutta, Santanu; Askelson, Margarita; Nasroulah, Federico; Zhang, Joshua; Brophy, Lynne; Bajorin, Dean F
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Experiences of Racism in Health Care and Medical Mistrust Shape Cancer Prevention and Control Behaviors Among Black Residents of Black Hawk County, Iowa: A Qualitative Study

种族主义在医疗保健领域的经历和对医疗机构的不信任如何影响爱荷华州布莱克霍克县黑人居民的癌症预防和控制行为：一项定性研究

期刊:Journal of Racial and Ethnic Health Disparities
影响因子:2.4
doi:10.1007/s40615-024-02199-3
Williams, Ashley N T; VanArsdale, Angela; Hirschey, Rachel; Askelson, Natoshia; Nash, Sarah H
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A Qualitative Study of Attitudes Toward HPV Vaccine Recommendation in Otolaryngology Clinics

耳鼻喉科诊所对HPV疫苗推荐态度的定性研究

期刊:Laryngoscope Investigative Otolaryngology
影响因子:1.7
doi:10.1002/lio2.70085
Janio, Emily A; Walker, Cori; Steere, Eliza; Seaman, Aaron T; Askelson, Natoshia; Pagedar, Nitin A
发表日期：2025
文献求助 收藏

Using immunization registry data to explore initiation of HPV vaccination at ages 9 and 10

利用免疫登记数据探讨9岁和10岁时HPV疫苗接种的启动情况

期刊:Human Vaccines & Immunotherapeutics
影响因子:
doi:10.1080/21645515.2025.2547432
Ryan, Grace W; Kahl, Amanda; Janio, Emily; Kintigh, Bethany; Callaghan, Don; Askelson, Natoshia M
免疫/内分泌
发表日期：2025
文献求助 收藏

Association of distance to diagnosis and area-based social measures with stage at diagnosis among Iowans with HPV-related cancers

爱荷华州HPV相关癌症患者确诊时的分期与诊断距离及基于地区的社会因素之间的关联

期刊:Cancer Causes & Control
影响因子:
doi:10.1007/s10552-025-02066-4
Janio, Emily; Kahl, Amanda R; Kpozehouen, Dosten; Askelson, Natoshia; Nash, Sarah H
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238

CheckMate 238 研究中接受辅助检查点抑制剂治疗的黑色素瘤切除术后复发患者接受全身治疗的疗效

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01448
Weber, Jeffrey; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O; Di Giacomo, Anna Maria; de la Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew; Fecher, Leslie A; Millward, Michael; Khushalani, Nikhil I; Queirolo, Paola; Long, Georgina V; Lobo, Maurice; Askelson, Margarita; Ascierto, Paolo A; Larkin, James
Checkpoint
黑色素瘤
发表日期：2024
文献求助 收藏